Sera Prognostics (SERA) Income from Continuing Operations (2020 - 2026)
Sera Prognostics (SERA) reported Income from Continuing Operations of 8425000.0 for Q1 2026, down 1.1% on a YoY basis from 8519054.12 in Q1 2025, and down 6.39% quarter-over-quarter from 7919000.0 in Q4 2025.
Sera Prognostics (SERA) Income from Continuing Operations (2020 - 2026) Analysis & Trends
Sera Prognostics has reported Income from Continuing Operations for 7 years, with the latest figure at 8425000.0 in Q1 2026.
- For the quarter ending Q1 2026, Income from Continuing Operations fell 1.1% year-over-year to 8425000.0; the trailing twelve-month figure through Mar 2026 stood at 32352000.0 (up 4.32% YoY), and the FY2025 full-year result was 32260000.0, up 4.88% from the prior year.
- Income from Continuing Operations for Q1 2026 stood at 8425000.0, down from 7919000.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was 7724000.0 in Q3 2023, with the low at 12304000.0 in Q1 2022.
- Historically, Income from Continuing Operations has averaged 9361352.94 across 5 years, with a median of 8436000.0 in 2024.
- Annual changes were most pronounced in 2022 — Income from Continuing Operations slumped 94.31% — and 2023, when it jumped 31.09%.
- Sera Prognostics' Income from Continuing Operations stood at 10436000.0 in 2022, then grew by 20.6% to 8286000.0 in 2023, then retreated by 5.67% to 8756000.0 in 2024, then climbed by 9.56% to 7919000.0 in 2025, then dropped by 6.39% to 8425000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 8425000.0 (Q1 2026), 7919000.0 (Q4 2025), and 7880000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 220.30 Mn |
| 10 | Sera Prognostics | 93.48 Mn | 93.48 Mn | -28,000.00 | -8.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.43 Mn |
| Dec 31, 2025 | -7.92 Mn |
| Sep 30, 2025 | -7.88 Mn |
| Jun 30, 2025 | -8.13 Mn |
| Mar 31, 2025 | -8.33 Mn |
| Dec 31, 2024 | -8.76 Mn |
| Sep 30, 2024 | -8.13 Mn |
| Jun 30, 2024 | -8.59 Mn |
| Mar 31, 2024 | -8.44 Mn |
| Dec 31, 2023 | -8.29 Mn |
| Sep 30, 2023 | -7.72 Mn |
| Jun 30, 2023 | -11.47 Mn |
| Mar 31, 2023 | -11.35 Mn |
| Dec 31, 2022 | -10.44 Mn |
| Sep 30, 2022 | -11.21 Mn |
| Jun 30, 2022 | -11.76 Mn |
| Mar 31, 2022 | -12.30 Mn |
| Dec 31, 2021 | -12.55 Mn |
| Sep 30, 2021 | -9.88 Mn |
| Jun 30, 2021 | -7.36 Mn |